Author's reply to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants
Corresponding Author
Salvatore Vaccarella
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Tel.: +33-4-72-73-8402, Fax: +33-4-72-73-8345
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, FranceSearch for more papers by this authorGary M. Clifford
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorRebecca Howell-Jones
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorPeter J.F. Snijders
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorSilvia Franceschi
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorfor the International Agency for Research on Cancer Multicentric Cervical Cancer Study Group
Search for more papers by this authorCorresponding Author
Salvatore Vaccarella
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Tel.: +33-4-72-73-8402, Fax: +33-4-72-73-8345
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, FranceSearch for more papers by this authorGary M. Clifford
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorRebecca Howell-Jones
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorPeter J.F. Snijders
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Search for more papers by this authorSilvia Franceschi
Infections and Cancer Epidemiology Group, International Agency for Research on Cancer, Lyon, France
Search for more papers by this authorfor the International Agency for Research on Cancer Multicentric Cervical Cancer Study Group
Search for more papers by this author
References
- 1 Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer, Apr 19, 2010. [Epub ahead of print].
- 2 Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 2009; 125: 2151–8.
- 3 Jacobs MV, Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995; 33: 901–5.
- 4 van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779–87.
- 5 Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008; 17: 1611–22.
- 6 Woo YL, Damay I, Stanley M, Crawford R, Sterling J. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens. J Virol Methods 2007; 142: 226–30.
- 7 Muñoz N, Bosch FX, Castellsagué X, Diaz M, de Sanjosé S, Hammouda D, Shah KV, Meijer CJ. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278–85.
Citing Literature
